Skip to main content
main-content

The American Diabetes Association | 82nd Scientific Sessions

News and expert insight from ADA 2022 | June 3 – 7

ADA 2022 highlights

06-07-2022 | ADA 2022 | Conference coverage | News

​​​​​​​ADA/KDIGO consensus: ‘Speaking the same language’ on CKD management

The ADA and KDIGO have produced a consensus statement on treating chronic kidney disease in people with diabetes.

06-06-2022 | ADA 2022 | Conference coverage | News

Annual wellness check may reduce amputation likelihood in high-risk locales

People with diabetes who attend an annual wellness check are significantly less likely to require a major lower extremity amputation within the same year, shows research from the US Diabetes Belt.

06-04-2022 | ADA 2022 | Conference coverage | News

​​​​​​​SURMOUNT-1 places tirzepatide weight loss efficacy within surgical range

A weekly injection of tirzepatide results in a substantial bodyweight reduction over and above that achieved with lifestyle intervention in people with obesity, show the SURMOUNT-1 findings.

06-04-2022 | ADA 2022 | Conference coverage | Video

SURMOUNT-1: Heralding a ‘golden age’ for obesity treatment

Louis Aronne discusses the results of SURMOUNT-1, and why he believes they may represent the start of a major shift in the treatment of people with obesity.

ADA 2022 research news

More research news from ADA 2022


Medicine Matters conference coverage is brought to you in partnership with medwireNews